LH vs. RMD: Labcorp vs. ResMed Stock Comparison
How do Labcorp (LH) and ResMed (RMD) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Labcorp (LH) and ResMed (RMD) both fall under the Health Care Equipment & Services industry group, but LH is classified in Health Care Providers & Services while RMD is classified in Health Care Equipment & Supplies.
| Profile Item | LH | RMD |
|---|---|---|
| Name | Labcorp Holdings Inc. | ResMed Inc. |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Providers & Services | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Services | Health Care Equipment |
| Market Capitalization | 29.77 billion USD | 33.10 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | March 29, 1990 | June 2, 1995 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | LH | RMD |
|---|---|---|
| Total Return (1Y) | 48.62% | -5.42% |
| Total Return (3Y, Annualized) | 23.39% | 18.99% |
| Total Return (5Y, Annualized) | 10.54% | -1.23% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | LH | RMD |
|---|---|---|
| Volatility (1Y, Annualized) | 24.36% | 30.80% |
| Beta (5Y) | 0.85 | 0.75 |
| Max Drawdown (5Y) | -34.61% | -49.04% |
| Avg. Volume (3M) | 721.05K | 1.32M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | LH | RMD |
|---|---|---|
| Sharpe Ratio (1Y) | 1.82 | -0.31 |
| Sortino Ratio (1Y) | 2.99 | -0.43 |
Profitability
ROE (TTM)
ResMed (RMD) at 26.40% sits in the top ROE quartile, while Labcorp (LH) at 11.44% is closer to the peer norm — stronger capital efficiency for RMD.
LH
Health Care Equipment & Services industry group
11.44%
- Max
- 47.61%
- Q3
- 14.36%
- LH
- 11.44%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
RMD
Health Care Equipment & Services industry group
26.40%
- Max
- 47.61%
- RMD
- 26.40%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
ResMed (RMD) at 27.79% retains a top-quartile share of revenue as profit, ahead of Labcorp (LH) at 6.88%, which keeps about the industry-typical share.
LH
Health Care Equipment & Services industry group
6.88%
- Max
- 29.35%
- Q3
- 9.33%
- LH
- 6.88%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
RMD
Health Care Equipment & Services industry group
27.79%
- Max
- 29.35%
- RMD
- 27.79%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
ResMed (RMD) at 34.82% operates in the top operating margin quartile, ahead of Labcorp (LH) at 10.91%, which runs around its industry’s norm.
LH
Health Care Equipment & Services industry group
10.91%
- Max
- 35.43%
- Q3
- 14.14%
- LH
- 10.91%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
RMD
Health Care Equipment & Services industry group
34.82%
- Max
- 35.43%
- RMD
- 34.82%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | LH | RMD |
|---|---|---|
| ROE (TTM) | 11.44% | 26.40% |
| ROA (TTM) | 5.48% | 14.76% |
| Net Margin (TTM) | 6.88% | 27.79% |
| Operating Margin (TTM) | 10.91% | 34.82% |
| Gross Margin (TTM) | 28.96% | 61.77% |
Growth
Revenue Growth
Both Labcorp (LH) at 7.25% and ResMed (RMD) at 9.85% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
Only one side can be read here: Labcorp (LH) reports EPS growth of 18.33%, ranked against its industry; ResMed (RMD) has no EPS growth figure this period.
Growth Metrics
| Metric | LH | RMD |
|---|---|---|
| Revenue Growth (YoY) | 7.25% | 9.85% |
| Revenue Growth (3Y CAGR) | 5.55% | 10.21% |
| EPS Growth (YoY) | 18.33% | -- |
| EPS Growth (3Y CAGR) | -9.19% | 19.64% |
Financial Strength
Current Ratio (MRQ)
Both Labcorp (LH) at 1.41 and ResMed (RMD) at 2.65 carry current ratio within their industries’ typical mid-ranges, suggesting balanced short-term liquidity relative to peers.
LH
Health Care Equipment & Services industry group
1.41
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- LH
- 1.41
- Q1
- 1.37
- Min
- 0.30
RMD
Health Care Equipment & Services industry group
2.65
- Max
- 7.59
- Q3
- 4.00
- RMD
- 2.65
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
ResMed (RMD) at 0.10 keeps leverage in the lower industry quartile, while Labcorp (LH) at 0.77 runs a more typical debt-to-equity mix.
LH
Health Care Equipment & Services industry group
0.77
- Max
- 1.88
- Q3
- 0.91
- LH
- 0.77
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
RMD
Health Care Equipment & Services industry group
0.10
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- RMD
- 0.10
- Min
- 0.00
Financial Strength Metrics
| Metric | LH | RMD |
|---|---|---|
| Current Ratio (MRQ) | 1.41 | 2.65 |
| Debt / Equity (MRQ) | 0.77 | 0.10 |
| Net Debt / EBITDA | 2.81 | -0.19 |
Dividends
Dividend Yield (TTM)
Both Labcorp (LH) at 0.79% and ResMed (RMD) at 1.03% yield above their industries’ entire benchmark ranges — high enough that dividend safety, not income, becomes the first question.
LH
Health Care Equipment & Services industry group
0.79%
- LH
- 0.79%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
RMD
Health Care Equipment & Services industry group
1.03%
- RMD
- 1.03%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Both Labcorp (LH) at 23.61% and ResMed (RMD) at 22.40% pay out more of their earnings than any of their industry peers — the thinnest cover in their groups, so dividend headroom deserves attention.
LH
Health Care Equipment & Services industry group
23.61%
- LH
- 23.61%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
RMD
Health Care Equipment & Services industry group
22.40%
- RMD
- 22.40%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | LH | RMD |
|---|---|---|
| Dividend Yield (TTM) | 0.79% | 1.03% |
| Dividend Payout Ratio (TTM) | 23.61% | 22.40% |
Valuation
P/E Ratio (TTM)
Both Labcorp (LH) at 30.05 and ResMed (RMD) at 21.43 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.
LH
Health Care Equipment & Services industry group
30.05
- Max
- 80.41
- Q3
- 47.62
- LH
- 30.05
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
RMD
Health Care Equipment & Services industry group
21.43
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- RMD
- 21.43
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
Labcorp (LH) at 2.04 is priced about in line with its industry on P/S ratio, while ResMed (RMD) at 5.77 sits in the pricier quartile — RMD costs more per dollar of sales.
LH
Health Care Equipment & Services industry group
2.04
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- LH
- 2.04
- Q1
- 1.10
- Min
- 0.03
RMD
Health Care Equipment & Services industry group
5.77
- Max
- 8.80
- RMD
- 5.77
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
On P/B ratio, both Labcorp (LH) at 3.36 and ResMed (RMD) at 5.56 are valued close to their industries’ norm against book — neither stands out from peers.
LH
Health Care Equipment & Services industry group
3.36
- Max
- 11.68
- Q3
- 6.12
- LH
- 3.36
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
RMD
Health Care Equipment & Services industry group
5.56
- Max
- 11.68
- Q3
- 6.12
- RMD
- 5.56
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | LH | RMD |
|---|---|---|
| P/E Ratio (TTM) | 30.05 | 21.43 |
| P/S Ratio (TTM) | 2.04 | 5.77 |
| P/B Ratio (MRQ) | 3.36 | 5.56 |
| Free Cash Flow Yield (TTM) | 3.55% | 3.92% |